Insilico Medicine IPO signals that AI‑native drug discovery is moving from promise to public markets with a central longevity narrative.

longevity.technology/news/insilic...

#longevity #AIinBiotech #DrugDiscovery #BiotechIPO #CapitalMarkets #DeepTech #LifeSciences